Estimating the potential survival gains by eliminating socioeconomic and sex inequalities in stage at diagnosis of melanoma

British Journal of Cancer
M J RutherfordPaul C Lambert

Abstract

Although inequalities in cancer survival are thought to reflect inequalities in stage at diagnosis, little evidence exists about the size of potential survival gains from eliminating inequalities in stage at diagnosis. We used data on patients diagnosed with malignant melanoma in the East of England (2006-2010) to estimate the number of deaths that could be postponed by completely eliminating socioeconomic and sex differences in stage at diagnosis after fitting a flexible parametric excess mortality model. Stage was a strong predictor of survival. There were pronounced socioeconomic and sex inequalities in the proportion of patients diagnosed at stages III-IV (12 and 8% for least deprived men and women and 25 and 18% for most deprived men and women, respectively). For an annual cohort of 1025 incident cases in the East of England, eliminating sex and deprivation differences in stage at diagnosis would postpone approximately 24 deaths to beyond 5 years from diagnosis. Using appropriate weighting, the equivalent estimate for England would be around 215 deaths, representing 11% of all deaths observed within 5 years from diagnosis in this population. Reducing socioeconomic and sex inequalities in stage at diagnosis would result in ...Continue Reading

References

Aug 28, 2004·European Journal of Epidemiology·Annika Rosengren, Lars Wilhelmsen
Mar 10, 2005·British Journal of Cancer·C ValeUNKNOWN UK Coordinating Committee for Cancer Research National Register of Cancer
Sep 26, 2007·Statistics in Medicine·Christopher P NelsonDavid R Jones
Oct 1, 2008·British Journal of Cancer·B RachetM P Coleman
Sep 17, 2009·British Journal of Cancer·D Cameron
Dec 4, 2009·British Journal of Cancer·M Abdel-RahmanM P Coleman
Dec 4, 2009·British Journal of Cancer·K RobbJ Wardle
Dec 4, 2009·British Journal of Cancer·P BaughanE Fletcher
Jul 1, 2010·British Journal of Cancer·B RachetM P Coleman
Aug 19, 2010·British Journal of Cancer·A PokhrelT Hakulinen
Nov 16, 2010·Computational Statistics & Data Analysis·Karthik Devarajan, Nader Ebrahimi
Dec 15, 2010·The Journal of Investigative Dermatology·Arjen JoosseUNKNOWN Munich Melanoma Group
May 6, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L M HollesteinE de Vries
May 25, 2011·Cancer Epidemiology·Paul C LambertHenrik Møller
Aug 31, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Rebecca J BeekenJane Wardle
Nov 19, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Libby EllisBernard Rachet
Jan 4, 2012·Journal of Cutaneous Pathology·Wolfgang Weyers
Apr 26, 2012·British Journal of Cancer·K SeppäE Läärä
Apr 19, 2013·International Journal of Cancer. Journal International Du Cancer·M J RutherfordD C Greenberg
Nov 22, 2013·International Journal of Cancer. Journal International Du Cancer·Lina JansenUNKNOWN GEKID Cancer Survival Working Group
Dec 10, 2013·The Lancet Oncology·Roberta De AngelisUNKNOWN EUROCARE-5 Working Group
Aug 22, 2014·Journal of Midwifery & Women's Health·Nicole S Carlson
Sep 6, 2014·British Medical Bulletin·Pippa CorrieChristine Parkinson

❮ Previous
Next ❯

Citations

Jul 29, 2016·Scandinavian Journal of Primary Health Care·Cédric RatJean-Michel Nguyen
Jun 8, 2017·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Luís AntunesMaria José Bento
Jan 8, 2021·JNCI Cancer Spectrum·Veronica Di CarloUNKNOWN US CONCORD Working Group

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Incidence & Mortality

Cancer has emerged as a global concern due to its increase in incidence and mortality. Efforts are underway to evaluate and develop action plans to reduce the global burden of cancer. Currently, lung cancer, breast cancer and prostate cancer are the leading causes of cancer mortality. Here is the latest research on cancer incidence and mortality.

Cancer Disparities

Cancer disparities refers to differences in cancer outcomes (e.g., number of cancer cases, related health complications) across population groups.